课题基金 / 基金详情

Early cellular immune responses to EBV

Early cellular immune responses to EBV
针对 EB 病毒的早期细胞免疫反应
批准号:
7101015
负责人:
SUMITA BHADURI-MCINTOSH
金额:
$13.66万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-01 至 2009-06-30

项目摘要

项目成果

SUMITA BHADURI-MCINTOSH的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal outlines a 5-year training program for the development of an academic career in Pediatric Infectious Disease. The candidate has completed residency training in Pediatrics, Ph.D. training in Molecular and Cell Biology, and fellowship training in Infectious Disease. She is now in the midst of enhancing her scientific skills through a unique blend of interdepartmental resources and expertise. The candidate's goal is to develop a command of cellular immunology as it relates to viruses by integrating EBV immunology research and a structured curriculum to enhance scientific knowledge in the fields of both virology and cellular immunology. Dr. George Miller, a renowned EBV virologist will mentor the candidate's scientific development. To enhance the experience, an advisory committee of highly respected immunologists studying diverse aspects of cellular immunology will provide scientific and career guidance. The candidate's research will examine the immune responses in the early stages of primary EBV infection and in the early stages of control of outgrowth of latently infected B cells in EBV-immune individuals. These questions will be addressed using a relevant and unique model experimental system that the candidate has developed. The goals are: 1. To identify the cells important in the initial response to EBV-LCL during primary infection and for the prevention of outgrowth of latently infected B cells in EBV seropositive individuals. 2. To determine if the responding cells are cytotoxic to LCL and characterize the mechanism of cell killing. 3. To experimentally modulate the composition and nature of the immune response by using exogenous molecules. This study will, for the first time, allow glimpses into the earliest interactions between the immune system and EBV without modification or amplification of the immune response. It is also expected to enhance the understanding of EBV lymphoproliferative diseases and have potential diagnostic and therapeutic implications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exposing synthetic lethal vulnerabilities in EBV-positive AIDS-NHL through novel replication dependency factors
  • 批准号:
    10700376
  • 项目类别:
  • 资助金额:
    $61.18万
  • 财政年份:
    2023
  • 负责人:
    SUMITA BHADURI-MCINTOSH
  • 依托单位:
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV
  • 批准号:
    10541285
  • 项目类别:
  • 资助金额:
    $68.93万
  • 财政年份:
    2022
  • 负责人:
    SUMITA BHADURI-MCINTOSH
  • 依托单位:
Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV
  • 批准号:
    10703446
  • 项目类别:
  • 资助金额:
    $75.07万
  • 财政年份:
    2022
  • 负责人:
    SUMITA BHADURI-MCINTOSH
  • 依托单位:
Host determinants of Epstein-Barr virus lytic cycle activation